Digital technologies like 3D printing, blockchain, and robotics are disrupting the traditionally regulated life sciences sector. This transformation brings new compliance risks around issues like:
- Partnerships with companies from other sectors that may not understand life sciences compliance
- Use of data from wearables and how it will be protected and used ethically
- Interactions with regulators to approve innovative, non-traditional products like those using artificial intelligence
- Power of informed patients who want treatments based on measurable outcomes
The high level of sector regulation remains, but methods of improper practices may change. Ongoing monitoring of issues like interactions with healthcare professionals and reliance on third parties will still be needed to mitigate corruption risks in this disrupted environment
The Impact and Use of Social Media in PharmacovigilanceCovance
This white paper examines how the influence and reach of the internet and social media can be harnessed to drive valuable outcomes for the PV industry. In this paper, we look at available regulatory guidelines, current state and future considerations for use of social media in PV, possible areas of influence, expected challenges, potential solutions and next steps.
This document discusses the current and future potential use of social media in pharmacovigilance (PV). It begins by providing context on the growth of social media and its current uses in biopharmaceutical communication. Regulatory guidance allows for screening of company websites and follow-up of reported safety issues. Currently, social media is primarily used for safety reporting, though opportunities exist to leverage it for data retrieval, analysis, and risk communication. Challenges include validating self-reported social media safety data and ensuring data privacy. Future areas of impact could include establishing social media as an additional reporting channel to increase patient reporting and connect with consumers.
This document proposes a model to provide individuals with aggregated information through personalized filters in order to make more informed decisions. It suggests separating information collection, interpretation and distribution to avoid bias. Contributors would collect various types of data and individuals could choose filters representing their values to receive relevant information through applications. This could help address social and environmental issues by changing behaviors and empowering democratic decision making. The document outlines technical feasibility and proposes establishing a non-profit pilot project to develop the concept.
The document discusses four key concepts for medical device executives to understand in order to succeed in China's rapidly growing medical devices market. First, executives must seize China's market opportunities as the market is expected to reach $50 billion by 2017. Second, they must understand the Chinese government's important role in regulating the industry and procurement processes. Third, executives should monitor healthcare reforms that could impact market access. Fourth, local competition is growing, so companies must balance global and local strategies to stay competitive. The medical devices market in China offers great potential for growth but also complexity that executives must navigate carefully.
Physicians in China are increasingly reluctant to meet with pharmaceutical sales representatives due to government investigations into bribery. Major pharmaceutical companies are changing their sales models in response, such as ending payments to physicians for speaking or conference participation. These changes may significantly impact sales volumes for some companies. The Chinese government is also transforming the healthcare system through expanded coverage, improved quality, and increased efficiency, which presents challenges and opportunities for pharmaceutical companies to adapt their strategies.
How Pharma Can Fully Digitize Interactions with Healthcare ProfessionalsCognizant
By building end-to-end IT ecosystems and understanding
preferred communications channels, pharmaceuticals
companies can create more engaging and fruitful digital
relationships with healthcare professionals.
Global Healthcare Information System Market will hit USD 54.0 Billion By 2020Sahil Sawant
Healthcare Information System by Delivery Sources (On-Premise Technology, Cloud Based Technology, Web Based Technology) Market for Pharmacy Information System, Hospital Information System and Laboratory Information System Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020
The Impact and Use of Social Media in PharmacovigilanceCovance
This white paper examines how the influence and reach of the internet and social media can be harnessed to drive valuable outcomes for the PV industry. In this paper, we look at available regulatory guidelines, current state and future considerations for use of social media in PV, possible areas of influence, expected challenges, potential solutions and next steps.
This document discusses the current and future potential use of social media in pharmacovigilance (PV). It begins by providing context on the growth of social media and its current uses in biopharmaceutical communication. Regulatory guidance allows for screening of company websites and follow-up of reported safety issues. Currently, social media is primarily used for safety reporting, though opportunities exist to leverage it for data retrieval, analysis, and risk communication. Challenges include validating self-reported social media safety data and ensuring data privacy. Future areas of impact could include establishing social media as an additional reporting channel to increase patient reporting and connect with consumers.
This document proposes a model to provide individuals with aggregated information through personalized filters in order to make more informed decisions. It suggests separating information collection, interpretation and distribution to avoid bias. Contributors would collect various types of data and individuals could choose filters representing their values to receive relevant information through applications. This could help address social and environmental issues by changing behaviors and empowering democratic decision making. The document outlines technical feasibility and proposes establishing a non-profit pilot project to develop the concept.
The document discusses four key concepts for medical device executives to understand in order to succeed in China's rapidly growing medical devices market. First, executives must seize China's market opportunities as the market is expected to reach $50 billion by 2017. Second, they must understand the Chinese government's important role in regulating the industry and procurement processes. Third, executives should monitor healthcare reforms that could impact market access. Fourth, local competition is growing, so companies must balance global and local strategies to stay competitive. The medical devices market in China offers great potential for growth but also complexity that executives must navigate carefully.
Physicians in China are increasingly reluctant to meet with pharmaceutical sales representatives due to government investigations into bribery. Major pharmaceutical companies are changing their sales models in response, such as ending payments to physicians for speaking or conference participation. These changes may significantly impact sales volumes for some companies. The Chinese government is also transforming the healthcare system through expanded coverage, improved quality, and increased efficiency, which presents challenges and opportunities for pharmaceutical companies to adapt their strategies.
How Pharma Can Fully Digitize Interactions with Healthcare ProfessionalsCognizant
By building end-to-end IT ecosystems and understanding
preferred communications channels, pharmaceuticals
companies can create more engaging and fruitful digital
relationships with healthcare professionals.
Global Healthcare Information System Market will hit USD 54.0 Billion By 2020Sahil Sawant
Healthcare Information System by Delivery Sources (On-Premise Technology, Cloud Based Technology, Web Based Technology) Market for Pharmacy Information System, Hospital Information System and Laboratory Information System Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020
Key lessons learned from the worldwide pandemic
Keynote presentation at the Digital Transformation of Pharmaceutical Industry conference organised by United Journal and Conferences on April 13th 2021
Our exclusive study reveals 20 key findings that will help health plans set the course for their digital member experience strategies in 2016 and beyond.
Value-Based Care and Healthcare Consumerism: Opportunities for Health IT and ...Cognizant
Health IT and technology solutions are central in the shift to value-based care and to meeting the demands of patient consumerism. Hurdles remain, but all primary players in the healthcare ecosystem, patients, providers and payers, are seeking more and better data, platform interoperability, real-time and actionable analytical insights, and more effective engagement.
Medical devices equipped for the futureBrand Acumen
The document discusses disruptive changes underway in the medical devices industry that will transform it over the next 5 years. It identifies 5 major disruptors: 1) a power shift to payers and providers who are focusing more on cost and value-based evidence, 2) heightened regulatory scrutiny that is increasing compliance costs, 3) unclear sources of innovation as R&D spending yields diminishing returns, 4) new healthcare delivery models that are shifting care settings out of hospitals, and 5) a need to serve lower socioeconomic classes in developing markets. The disruptors threaten $34 billion in industry profits by 2020 but taking appropriate measures could help maintain revenue growth and offset margin declines, preserving significant value for medical device companies.
Managing costs and delivering savings continues to be a focal
point of the procurement agenda. However, procurement also
has to focus on driving innovation to ultimately help drive
the growth agenda. This is against a backdrop of increasing
regulation that requires more transparency governance and
compliance in ever-increasing competitive markets.
The document discusses trends impacting the healthcare industry and their implications for healthcare marketers. It summarizes that the industry is undergoing unprecedented changes driven by structural challenges, the Affordable Care Act, personalized medicine, and advances in health IT, digital, social and mobile technologies. These changes are impacting drug development, healthcare delivery, and pricing and payment models. The document also discusses trends specifically in pharmaceuticals/biotechnology, diagnostics/personalized medicine, and healthcare IT/analytics and the challenges they pose for healthcare marketers.
Healthcare - Customer-Centric Healthcare Best Practices for CIO and CISOsNicholas Christiano Jr.
The document discusses the challenges healthcare CIOs and CISOs face in providing secure yet accessible patient information in light of new regulations. It notes that while healthcare organizations have traditionally focused on keeping data private, new rules will require all patient data to be online by 2016. This presents a dilemma for technology leaders who must ensure stringent security while supporting more open access. The document provides recommendations for best practices to address this challenge, including looking to other industries like banking that balance security and accessibility well. It stresses the importance of selecting the right technologies and solutions to protect against breaches while meeting patient and regulatory needs.
The document summarizes a panel discussion on digital health held by the INSEAD Healthcare Club of Switzerland. It discusses how digital health has the potential to transform life sciences through technologies like sensors, data collection, and precision medicine. However, significant regulatory hurdles around data sharing and privacy still exist. While companies like Bristol-Myers Squibb and Novartis are pursuing digital health projects, it is unclear which players like pharmaceutical companies, technology giants, insurers, or patients will ultimately lead the transformation. The panelists debated these issues and shared lessons learned from their experiences in digital health.
Healthcare Rx: The Rise of the Empowered ConsumerCognizant
Market and digital forces have combined to enable the healthcare industry to treat much of what ails it — or be supplanted by newcomers who can more quickly seize the digital high ground.
The Digital Metamorphosis of the Pharma IndustryLen Starnes
The document discusses the digital transformation of the pharmaceutical industry. It notes changes like aging populations, rising healthcare costs, empowered patients, and new business models. Doctors are becoming "digital" and using social networks and mobile devices. Patients are forming online communities to share health data. The document suggests pharmaceutical companies must adapt by using digital tools, empowering sales forces with mobile technology, and building trust with doctors, patients, and online communities. Pharma must learn from the digital behaviors of doctors and patients to keep pace with their evolving expectations.
Why is Pharmacovigilance required in pharmaceutical markets for all countries? Majorly it is due to adverse drug reactions (ADR) that lead to severe illness, permanent side effects, and even death.
Unleashing the Potential of Social Media in Drug Safety Exploring the Increas...Covance
Pharmacovigilance has grown more complex over the past decade with higher data volumes, changing regulations, rise of social media, and innovative digital advances. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
Providers are seeking ways to incrementally collect more payments from patients to address rising healthcare costs. Traditional online payment methods were limited and did not promote widespread adoption of e-payments. Newer approaches aim to improve the patient experience and encourage more online payments through options like no-login payments, integrating payment portals with electronic health records using single sign-on, utilizing mobile technologies, and providing electronic document storage. These methods may help providers collect more payments, more easily and faster.
This document discusses the importance of identity protection in the age of widespread data breaches. It notes that data breaches are now very common across many industries and can compromise personal information like names, addresses, and social security numbers. While companies often offer free credit monitoring after a breach, the document argues this only provides limited protection and may only monitor one credit bureau. A more comprehensive identity protection solution is needed that includes identity monitoring, prevention services, resolution assistance if fraud occurs, and monitoring of the deep/dark web where stolen data is sometimes traded. Such robust protection is necessary given that the effects of a data breach on a person's identity can last for years.
Rethinking Health Plan Business Models for the Emerging On-Demand Digital Eco...Cognizant
Even as on-demand healthcare platforms disrupt the industry, they create possibilities for new value propositions, partnerships and business models that will further reshape the cost and delivery of care.
iHT2 Health IT Summit Boston 2013 – Scott Lundstrom, Group Vice President Presentation, IDC Health Insights "IT Strategies for an Uncertain Future - Embracing Change and Innovation"
Presentation "IT Strategies for an Uncertain Future - Embracing Change and Innovation"
The widespread changes demanded by reform continue to create angst and opportunities for healthcare providers. Quality, cost and compliance initiatives, changing business models, and new care delivery technologies are all demanding our attention. Uncertainty is high, but the call to action is strong, and there is tremendous pressure to show broadly based progress across the technology portfolio. How can IT and the business move forward on a common plan in these uncertain times? Leading organizations are already building a platform for the future. By focusing on reducing costs, improving quality, and supporting business innovation technology, significant progress can be made to support a broad range of possible post reform business models. By focusing on a core group of enabling technologies health organizations can become better prepared to survive in the post reform market. What are the core key enabling technologies required by any health organization in the future? Where should resource constrained organizations focus their attention?
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
The Postdigital Enterprise: Harnessing Change, Managing DisruptionCorey O'Neal
As mobility, social business, cloud computing and analytics evolve, each may represent a significant opportunity to enable or transform enterprises, markets and industries. But collectively, could these capabilities create significant disruption in the postdigital enterprise? We'll discuss:
Characteristics of the postdigital era, including transparency, consumerization and a renewed focus on the individual.
Business value, risks, and considerations for the intersection of mobile, social, analytics, and cloud.
Examples of postdigital innovation and disruption of operating and business models.
Learn about the benefits of harnessing mobility, social business, cloud computing and analytics, and explore how the intersection of these capabilities can transform your organization into a postdigital enterprise.
For more: http://www.deloitte.com/view/en_US/us/Insights/Browse-by-Content-Type/dbriefs-webcasts/283129725a782310VgnVCM2000001b56f00aRCRD.htm
AvePoint - Managing the SharePoint Disruptiongarthluke
Managing the SharePoint Disruption. Ensuring your business gain exceeds your business pain.
In many organisations, SharePoint is a disruptive technology: it’s no longer business-as-usual for managers, for users, or for IT. SharePoint shines a spotlight on everything that’s good and bad about your company’s business processes, project management, change management, information management policies and IT service delivery.
This presentation will explore the lessons learned and common themes from thousands of organisations, large and small - from IT professionals, managers, developers, end users and CIOs around the globe. This comprehensive discussion will highlight the business, cultural and technical impact of SharePoint on an organisation - the business values and the “gotchas”. You’ll learn the steps you can take to plan for and implement SharePoint as a platform that will support a dynamic enterprise.
You will take away a framework within which to understand and communicate the role of SharePoint in your organisation, a punch list of issues to consider in your planning and deployment and an understanding of the business, technical, cultural and procedural components of a successful SharePoint implementation.
Key lessons learned from the worldwide pandemic
Keynote presentation at the Digital Transformation of Pharmaceutical Industry conference organised by United Journal and Conferences on April 13th 2021
Our exclusive study reveals 20 key findings that will help health plans set the course for their digital member experience strategies in 2016 and beyond.
Value-Based Care and Healthcare Consumerism: Opportunities for Health IT and ...Cognizant
Health IT and technology solutions are central in the shift to value-based care and to meeting the demands of patient consumerism. Hurdles remain, but all primary players in the healthcare ecosystem, patients, providers and payers, are seeking more and better data, platform interoperability, real-time and actionable analytical insights, and more effective engagement.
Medical devices equipped for the futureBrand Acumen
The document discusses disruptive changes underway in the medical devices industry that will transform it over the next 5 years. It identifies 5 major disruptors: 1) a power shift to payers and providers who are focusing more on cost and value-based evidence, 2) heightened regulatory scrutiny that is increasing compliance costs, 3) unclear sources of innovation as R&D spending yields diminishing returns, 4) new healthcare delivery models that are shifting care settings out of hospitals, and 5) a need to serve lower socioeconomic classes in developing markets. The disruptors threaten $34 billion in industry profits by 2020 but taking appropriate measures could help maintain revenue growth and offset margin declines, preserving significant value for medical device companies.
Managing costs and delivering savings continues to be a focal
point of the procurement agenda. However, procurement also
has to focus on driving innovation to ultimately help drive
the growth agenda. This is against a backdrop of increasing
regulation that requires more transparency governance and
compliance in ever-increasing competitive markets.
The document discusses trends impacting the healthcare industry and their implications for healthcare marketers. It summarizes that the industry is undergoing unprecedented changes driven by structural challenges, the Affordable Care Act, personalized medicine, and advances in health IT, digital, social and mobile technologies. These changes are impacting drug development, healthcare delivery, and pricing and payment models. The document also discusses trends specifically in pharmaceuticals/biotechnology, diagnostics/personalized medicine, and healthcare IT/analytics and the challenges they pose for healthcare marketers.
Healthcare - Customer-Centric Healthcare Best Practices for CIO and CISOsNicholas Christiano Jr.
The document discusses the challenges healthcare CIOs and CISOs face in providing secure yet accessible patient information in light of new regulations. It notes that while healthcare organizations have traditionally focused on keeping data private, new rules will require all patient data to be online by 2016. This presents a dilemma for technology leaders who must ensure stringent security while supporting more open access. The document provides recommendations for best practices to address this challenge, including looking to other industries like banking that balance security and accessibility well. It stresses the importance of selecting the right technologies and solutions to protect against breaches while meeting patient and regulatory needs.
The document summarizes a panel discussion on digital health held by the INSEAD Healthcare Club of Switzerland. It discusses how digital health has the potential to transform life sciences through technologies like sensors, data collection, and precision medicine. However, significant regulatory hurdles around data sharing and privacy still exist. While companies like Bristol-Myers Squibb and Novartis are pursuing digital health projects, it is unclear which players like pharmaceutical companies, technology giants, insurers, or patients will ultimately lead the transformation. The panelists debated these issues and shared lessons learned from their experiences in digital health.
Healthcare Rx: The Rise of the Empowered ConsumerCognizant
Market and digital forces have combined to enable the healthcare industry to treat much of what ails it — or be supplanted by newcomers who can more quickly seize the digital high ground.
The Digital Metamorphosis of the Pharma IndustryLen Starnes
The document discusses the digital transformation of the pharmaceutical industry. It notes changes like aging populations, rising healthcare costs, empowered patients, and new business models. Doctors are becoming "digital" and using social networks and mobile devices. Patients are forming online communities to share health data. The document suggests pharmaceutical companies must adapt by using digital tools, empowering sales forces with mobile technology, and building trust with doctors, patients, and online communities. Pharma must learn from the digital behaviors of doctors and patients to keep pace with their evolving expectations.
Why is Pharmacovigilance required in pharmaceutical markets for all countries? Majorly it is due to adverse drug reactions (ADR) that lead to severe illness, permanent side effects, and even death.
Unleashing the Potential of Social Media in Drug Safety Exploring the Increas...Covance
Pharmacovigilance has grown more complex over the past decade with higher data volumes, changing regulations, rise of social media, and innovative digital advances. **Disclaimer: This article was previously published. Sciformix is now a Covance company.
Providers are seeking ways to incrementally collect more payments from patients to address rising healthcare costs. Traditional online payment methods were limited and did not promote widespread adoption of e-payments. Newer approaches aim to improve the patient experience and encourage more online payments through options like no-login payments, integrating payment portals with electronic health records using single sign-on, utilizing mobile technologies, and providing electronic document storage. These methods may help providers collect more payments, more easily and faster.
This document discusses the importance of identity protection in the age of widespread data breaches. It notes that data breaches are now very common across many industries and can compromise personal information like names, addresses, and social security numbers. While companies often offer free credit monitoring after a breach, the document argues this only provides limited protection and may only monitor one credit bureau. A more comprehensive identity protection solution is needed that includes identity monitoring, prevention services, resolution assistance if fraud occurs, and monitoring of the deep/dark web where stolen data is sometimes traded. Such robust protection is necessary given that the effects of a data breach on a person's identity can last for years.
Rethinking Health Plan Business Models for the Emerging On-Demand Digital Eco...Cognizant
Even as on-demand healthcare platforms disrupt the industry, they create possibilities for new value propositions, partnerships and business models that will further reshape the cost and delivery of care.
iHT2 Health IT Summit Boston 2013 – Scott Lundstrom, Group Vice President Presentation, IDC Health Insights "IT Strategies for an Uncertain Future - Embracing Change and Innovation"
Presentation "IT Strategies for an Uncertain Future - Embracing Change and Innovation"
The widespread changes demanded by reform continue to create angst and opportunities for healthcare providers. Quality, cost and compliance initiatives, changing business models, and new care delivery technologies are all demanding our attention. Uncertainty is high, but the call to action is strong, and there is tremendous pressure to show broadly based progress across the technology portfolio. How can IT and the business move forward on a common plan in these uncertain times? Leading organizations are already building a platform for the future. By focusing on reducing costs, improving quality, and supporting business innovation technology, significant progress can be made to support a broad range of possible post reform business models. By focusing on a core group of enabling technologies health organizations can become better prepared to survive in the post reform market. What are the core key enabling technologies required by any health organization in the future? Where should resource constrained organizations focus their attention?
The aim of this presentation is to help Digital Marketing managers to implement an efficient e-marketing strategy in the particular and constrained environment of the pharmaceutical industry. This presentation can also be a good opportunity for Operational Marketing professionals jammed with the traditional 4p to realise that implementing a 360° marketing strategy is not only aligning Web and Marketing (or vice versa).
I took the opportunity of the success of my previous release to enhance and complete some slides in this V2.0. You will discover how a Biopharmaceutical company (Celgene) has taken a good start after my advises in 2010 and how they have implemented an e-marketing strategy with the evolution of their Internet portals and their connections to medical portals.
It seems to me that you can significantly improve your knowledge of e-marketing tactics with free tools in order to audit and monitor your consumer’s behaviours in the digital space by reading my other presentation: Digital Marketing Management.
The Postdigital Enterprise: Harnessing Change, Managing DisruptionCorey O'Neal
As mobility, social business, cloud computing and analytics evolve, each may represent a significant opportunity to enable or transform enterprises, markets and industries. But collectively, could these capabilities create significant disruption in the postdigital enterprise? We'll discuss:
Characteristics of the postdigital era, including transparency, consumerization and a renewed focus on the individual.
Business value, risks, and considerations for the intersection of mobile, social, analytics, and cloud.
Examples of postdigital innovation and disruption of operating and business models.
Learn about the benefits of harnessing mobility, social business, cloud computing and analytics, and explore how the intersection of these capabilities can transform your organization into a postdigital enterprise.
For more: http://www.deloitte.com/view/en_US/us/Insights/Browse-by-Content-Type/dbriefs-webcasts/283129725a782310VgnVCM2000001b56f00aRCRD.htm
AvePoint - Managing the SharePoint Disruptiongarthluke
Managing the SharePoint Disruption. Ensuring your business gain exceeds your business pain.
In many organisations, SharePoint is a disruptive technology: it’s no longer business-as-usual for managers, for users, or for IT. SharePoint shines a spotlight on everything that’s good and bad about your company’s business processes, project management, change management, information management policies and IT service delivery.
This presentation will explore the lessons learned and common themes from thousands of organisations, large and small - from IT professionals, managers, developers, end users and CIOs around the globe. This comprehensive discussion will highlight the business, cultural and technical impact of SharePoint on an organisation - the business values and the “gotchas”. You’ll learn the steps you can take to plan for and implement SharePoint as a platform that will support a dynamic enterprise.
You will take away a framework within which to understand and communicate the role of SharePoint in your organisation, a punch list of issues to consider in your planning and deployment and an understanding of the business, technical, cultural and procedural components of a successful SharePoint implementation.
Solving Compliance Challenges Across Digital ChannelsR2integrated
At this years Net Finance Conference r2i's VP of Technology, Nick Christy, spoke about how financial institutions are driven by a core set of business goals and how compliance and regulatory laws can stand in the way of achieving the goals.
This document discusses cycles of disruption from external events like natural disasters, man-made disasters, political unrest, and financial crises. It presents a framework for risk appetite with three levels: governance level focusing on risk appetite and strategy, planning level analyzing risk exposure, and operating level identifying and monitoring risks. Finally, it shows how integrating risk management into strategic planning can help a large retail organization rationalize its footprint to fund future growth.
Sara Melki is a 28-year-old Lebanese fashion designer who runs her own successful brand and business in Beirut. She has an artistic background and was influenced by her internship with fashion house Maison Rabih Kayrouz. While Lebanon has many famous fashion designers, Melki draws inspiration from artists, travel, and history. She believes her background in art helps her take risks and avoid trends. Though Lebanon poses economic challenges, Melki is optimistic and plans to open a new store to reach more customers.
This document provides an overview of a webinar presentation about QlikView 9 healthcare intelligence software. The webinar objectives are to review challenges in healthcare, introduce QlikView and how it addresses those challenges, and share client success stories. QlikView provides business intelligence solutions that enable fast implementations, easy use, powerful analysis of large data volumes, flexibility, integrated dashboards and reporting, and low costs. Customer case studies highlight benefits like improved operations, cost savings, and revenue cycle management.
Carbon matters print: global tipping pointsAlan Laubsch
The root cause of our escalating climate crisis is unpriced carbon emissions. A global price for carbon is the most sensible policy response, and is inevitable. Carbon pricing will speed up the shift to renewables, especially solar power, which is doubling consistently every 2 years and will be the dominant source of energy by 2026.
Innovation In Professional Services - Sectors Facing Digital DisruptionMatthew Ho
This document discusses innovation in professional services and provides examples of how companies have innovated. It suggests that the world's largest taxi, media, and accommodation providers own no assets in their industries. It then discusses how Australian businesses spend on freelance marketplaces and new skills in demand. Examples of professional services available on marketplaces are provided. The document discusses digital disruption in accounting and how accounting tasks are being replaced by software. It provides a case study of Deloitte Private and their software. It suggests that disruption is close and outlines models of corporate innovation and case studies of how companies have innovated.
Board Governance and Emerging Risks in the C21FERMA
On 10 July 2015 FERMA, ecoDa and AIG organised jointly a event in Brussels that brought together directors, risk managers and insurers from across Europe to share perspectives on the quality of the Risk conversation at Board level and to generate ideas for improving it.
Risk Management in the Age of DisruptionAlan Laubsch
We have entered a great age of disruption, where complexity drives exponential change and systemic risk. This calls for a new risk management paradigm, from "predict & control" to "sense & respond." The application of network science allows us to filter signal from noise, and focus on critical pressure points. Financial Cartography raises environmental awareness to help us navigate challenging terrain. Ultimately, such maps can serve as mass collaboration platforms to spark social risk intelligence.
An Introduction to Data Gravity by John Tkaczewski of FileCatalystETCenter
You're probably familiar with the concept of data gravity, even if you’ve never heard the term before. The emerging term and its concept are becoming increasingly popular as file sizes continue to grow at exponential rates, and cloud storage popularity becomes mainstream. This session will introduce the concept of data gravity, the factors at play, and how file transfer will play a role in the future.
EU/US boards’ approach to cyber risk governance - webinar presentationFERMA
The 4th webinar is being hosted by the European Confederation of Directors' Associations (ecoDa), AIG, and the Federation of European Risk Managers' Associations (FERMA) and in close cooperation with the Internet Security Alliance (ISA).
it includes a Risk Manager’s’ perspective about the necessity to provide organisations with decision-support tools for mitigation and recommendations for risk transfer.
Neel Banerjee of Urban Airship and Gene Ehrbar of ISITE Design discuss strategy and tips for making digital disruption a part of business large and small.
Digital Transformation: a model to master disruptionScopernia
This document discusses the ongoing digital disruption that is transforming industries and the need for companies to undergo a digital transformation. It emphasizes that digital disruption will impact all industries by 2020 and the average lifespan of companies on the S&P 500 is decreasing. The document provides advice on how companies can transform, including developing a 2020 vision for how digital will change the business, establishing different models for incremental, strategic, and breakthrough innovation, and ensuring digital leadership from the CEO and board level on down. It stresses the importance of focusing on solving customer problems rather than just having good ideas.
When you hear “digital” most people start to think about Google, Facebook or other technology companies. But now transforming into a digital company is the strategic objective for many companies across multiple sectors. We see digitisation as the driving strategy for many global business; GE’s strategy is to become the first digital industrial company and is moving its headquarters to Boston to be closer to MIT (Massachusetts Institute of Technology). Deutsche Bank wants to transform into a digital bank, and Sephora is digitising the world of beauty. The transformation is not just how these companies manage clients and deliver services through the web and smart phone apps, but back office processes, enhancing organisational agility, speeding up supply chains and recreating whole service offerings to make life easier or better for clients.
Innovation and digital disruption in professional servicesTapmint
This is a presentation for http://tapmint.com which I gave internally at one of the world's largest professional services firms. It discusses digital disruption in financial services, professional services and accounting services.
Various models of corporate innovation are also highlighted. Case studies of 3 companies are provided - Suncorp Group, Sensis and Carsales. Finally, I provide some thoughts on implementation.
Disruption and digital disruption 2016Dirk Laverge
disruption in our economy, and the impact of digital transformation
1) trends
2) drivers for change
3) business models
4) how to respond to the disruption?
How life sciences can win with blockchainToni Borges
The IBM Institute for Business Value surveyed 205 life sciences executives in 18 countries. The study, conducted in collaboration with the Economist Intelligence Unit (EIU), included chief financial officers (CFOs), chief technology officers (CTOs) and chief information officers (CIOs). Those participating had to meet specific criteria: they were either working with — or planning to work with — blockchains in the next 12 months, and they needed to be familiar with the blockchain strategies of their organizations.
This document discusses concepts related to the global health-tech industry. It provides an overview of key topics including the healthcare and life sciences industry in 2020, technologies and startups disrupting the status quo, a focus on the medical device industry globally and in India, and a concept note on syringe counterfeiting. The document also analyzes funding trends in 2020, highlights major disruptors like telemedicine, and provides snapshots on medical devices and new anti-counterfeiting technologies.
To lead digital transformation, CIOs at pharmaceutical and medical device companies need to adopt new workstyles and mindsets, including C-level relationship-building and the ability to both catalyze innovation and find the talent to execute on it.
Practical guide on private funding for EU eHealth SMEsgetslidesdeck
The document discusses trends in digital health and investment in Europe compared to the US. Some key points:
1) Venture funding for digital health has grown rapidly in recent years on both sides of the Atlantic, with over $4 billion invested in the US in 2014 alone. However, investment in Europe still lags behind, though some large funding rounds have occurred.
2) Most digital health startups in Europe are still at the seed stage, but more are qualifying for Series A funding and beyond in recent years.
3) Factors holding back more investment in Europe include digital health initiatives still being in early stages of development and a fragmented healthcare system compared to the larger US market. Interviews with an investor
How the Internet of Things Is Transforming Medical DevicesCognizant
The Internet of Things (IoT) should be a central focus for medical device companies, as IoT dramatically expands and enhances the field for the entire stakeholder ecosystem. We offer a roadmap for medical devices companies seeking a wise and effective path forward with IoT.
The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.
The document discusses how pharmaceutical companies can leverage social media to enhance pharmacovigilance and patient safety. It proposes a 4-step social media model: 1) establish keywords related to side effects, 2) listen to patient conversations on social media, 3) generate reporting and analytics on collected data, 4) respond to patient concerns. Adopting this approach allows companies to identify risks early, minimize reputation risks, and manage adverse events, helping boost patient safety.
Development Standards and Regulations for HealthTechElinext
Wearables, surgery robots, wellness platforms, and digital doctors. The new healthcare landscape is bright, full of novelties and breaking ideas. But before entering this market, you should learn the basic regulations and standards for HealthTech products. We gathered all the information for you in our new infographic.
Just I need 2 pages and you can make a summary of the answer that i .docxssuser47f0be
Just I need 2 pages and you can make a summary of the answer that i but it
What role has technology played in the evolution of marketing in healthcare? To what extent has the Internet changed the way markets are organized?
These approaches allowed the provider not only to micromanage the marketing effort but also to customize the approach for specific target audiences. The ability to cross-sell, up-sell, and induce repeat sales offered a significant advantage over standard advertising approaches. These approaches also ensured ongoing communication with customers and prospective customers and kept customers involved with the organization.
The most recent stage in the evolution of marketing on the part of provider organizations is Internet marketing. This development in itself reflects a number of stages. While initially serving an information-and-referral function, provider-sponsored web sites have evolved beyond an inventory of services to offer a range of interactive functions that encourage two-way communication between the provider and its customers. Not only does the Internet serve as a mechanism for attracting attention to the provider, but it also offers a means of keeping customers engaged once they become a part of the system.
The rise in healthcare media and the interactive technology of the Internet com- bined to create an informed consumer who was more empowered with infor- mation than at any other time in human history.
Despite their presumed scientific orientation and interest in advancing their practices, many physicians are reluctant to even consider new technology. Physicians tend to be risk-averse in this regard and resistant to anything that requires a change in practice operations. Because they already feel sensory overload, the thought of a major new initiative is overwhelming for most of them. Furthermore, a surprising number of physicians, especially older ones, suffer from computer phobia. They did not grow up with computers; even if they concede the potential, they are aware of horror stories from other practices that had negative experiences with IT.
Physicians also typically take a hands-on approach to their patients—that is, they want to have their medical records in hand when addressing patient needs. The thought of interjecting a computer between doctor and patient is alien to many of them. There are also concerns over the confidentiality of electronic patient records; these concerns have only been heightened by recent enactment of HIPAA (Health Insurance Portability and Accountability Act) regulations. Physicians are also put off by the cost of IT, especially when they virtually never budget any funds for such expenditures. Even though most technology purchases could be financed on reasonable terms, the sticker shock experienced by physicians deters many from thoughtful pursuit of possible solutions.
Physicians also serve as customers for a variety of organizations providing support services, including billin ...
This document provides an overview of the health tech industry and key trends. It discusses how the industry has adopted digital technologies across areas like drug manufacturing, clinical trials, hospitals, and care services. The COVID-19 pandemic further increased adoption rates. The document analyzes funding and deal size data from the past 5 years to identify fast growing segments like telemedicine, anti-counterfeiting tech, and the rise of tech giants in healthcare investing. Post-pandemic, virtual consultations are expected to become more mainstream. The future of healthcare is predicted to rely more on technologies like artificial intelligence, digital tools, and data analytics.
The Work Ahead in Life Sciences: Cures at the Speed of DigitalCognizant
COVID-19 accelerated digital transformation in the life sciences industry. Life sciences companies had to quickly adapt their operations to digital ways of working and doing business. This included moving to remote work and online engagement with clinicians and patients. As a result, digital technologies have become an operational imperative rather than just a strategic priority. Looking ahead, life sciences companies expect to generate double the revenue from digital channels by 2023 compared to today. They will need to overhaul their business models to support new digitally-enabled care delivery models. Key processes like clinical research and development will become more augmented by technologies like IoT, AI, analytics and automation in the next three years.
This document discusses how life sciences companies can address challenges in the industry by adopting new technologies. It identifies trends putting pressure on companies, such as new regulations and shifting customer expectations. It then presents solutions that technology can provide: a new multi-channel commercial model to better engage customers; business agility through cloud-based platforms to accelerate innovation; and a focus on outcomes through data analytics and patient services to improve care. Adopting modern cloud technologies, the document argues, is key for companies to transform their business models and adapt to changes in the industry environment.
In this presentation, I tried to succinctly discuss the future technology trends and explain how they can impact the healthcare industry. Also Business Transformation, as a key to tackle, has been discussed.
Medtech Joining the Digital Party - December 2015Megan Aparicio
The document discusses how the medical technology (medtech) industry has been slower than other industries and sectors of healthcare to embrace digital transformation. A survey found that only 33% of medtech companies see digital technologies as a major disruptor compared to 57% across all industries. Medtech companies also lag in having a clear digital strategy, properly structured organizations for digital initiatives, and appointing dedicated digital leadership roles. For successful digital transformation, the document recommends medtech companies focus on strategic clarity, appropriate structures, defining ownership of digital efforts, and hiring the right digital talent.
The document discusses risk management in companies. It provides questions for senior executives and IT executives about risks to the business from data security, regulatory compliance, and technological issues. It also summarizes statistics about the high costs of data breaches for companies and discusses how outsourcing some risk management functions can help companies focus on compliance in today's complex regulatory environment.
Blockchain has many potential applications in health including: medical research, information sharing/interoperability, digital identity management, supply chain management, and financial/insurance applications. Some exemplary uses are improving medical records management, clinical data collection, supply chain traceability for anti-counterfeiting, and life-cycle management of medical equipment. Key players like Merck, SAP, GSK and Pfizer are exploring blockchain for applications like supply chain management, fighting fake drugs, and traceability.
The 10 companies booming in healthcare sector smallinsightscare
Development is a continuous process in any sector. It brings in more comfort, more precision, and more enhanced way of living.Acknowledging the remarkable contribution of the leading companies in the care sector, we bring to you the special issue of “The 10 Companies Booming in Healthcare Sector”.
UiPath: Insurance in the Age of Intelligent AutomationUiPath
This paper will explain what benefits Robotic Process Automation (RPA) brings to the Insurance industry, how
it tackles the most sensitive pain points and offers guidelines on
building a successful RPA capability.
Real uses cases will illustrate how other companies developed their RPA deployments. You will also find out what’s in store
for intelligent process automation (IPA), as AI and cognitive tools merge with RPA.
Finally, the paper will demonstrate that insurers must catch the RPA train before it is too late if they want to stay relevant in an ever so challenging and rapidly evolving market.
2. 2 | Digital disruption in the life sciences sector
Digital innovation, sector convergence,
3D printing, blockchain, robotics: all
terms that — until recently — were not
part of the life sciences lexicon. Yet the
traditional way in which this market sector
has been defined is being rewritten, as
businesses from other sectors enter
this space. The expectations of key
stakeholders, including patients, health
care professionals and regulators, are
changing as digitalization plays an
increasingly important role.
What does this mean for a relatively
traditional sector that has experienced
high levels of regulation and enforcement
activity? Will the bribery and corruption
risks stay as it is going through this major
transformation? What does the “Industrial
Revolution 4.0”1
mean for compliance
risks?
Digitalization is widely seen as a
positive. It can significantly increase
transparency of a company’s operations
and impact its efficiency over the
product cycle. In life sciences, it is a
by-product of stakeholders’ changing
expectations — and their focus on
outcome. The incorporation of technology
and increased use of data directly impacts
the product life cycle — from research
and development through to sales and
marketing.
Throughout this transformation, the
high level of sector regulation remains
unchanged. While methods of improper
practice may change, the risks of bribery
and corruption prevail, supplemented by
new types of compliance risks.
Digital disruption in the life sciences sector: will
corruption risks also be disrupted?
Background — regulatory environment
Changing risk landscape in a disrupted sector
It is common knowledge that the life
sciences sector continues to be a focus for
regulatory enforcement activity. The life
sciences sector is unique for a variety of
reasons, including the scale of companies’
interactions with health care professionals
(HCPs), who, in many countries work for
The digital transformation will almost
certainly lead to new compliance risks and
the evolution of existing risks, including
the following.
Alliances with partners from
other sectors
Are your new partner’s compliance
standards on a par with yours? What
about its corporate culture?
In the past two years in particular, non-
life sciences companies have entered
the sector through partnerships with
traditional players. Large companies
from the technology, consumer products
and automotive sectors, among others,
have established their own health
care divisions. While this convergence
of sectors can be seen as a positive
development for the future of health care,
these companies will rarely be familiar
or are affiliated with the government,
and therefore can be considered public
officials under relevant bribery laws.
Recent enforcement activity by regulators
in the US and UK, as well as other major
markets including Germany and China,
with the detailed regulatory specifics
of the sector, such as those involving
interactions with health care professionals
or level of reliance on third parties. As
a result, those partnerships that are
unmonitored — or that skip the necessary
comprehensive pre- and post-deal
compliance due diligence process — may
be more exposed to compliance risks.
Partnerships/alliances with
start-ups
How well does your new partner protect
its own IP? How will it protect yours?
The focus of a start-up is to achieve
successful growth through the discovery
and launch of a unique product. The
establishment of an effective compliance
framework in these companies may be
impacted by the level of budget and
resource availability. It is therefore
important for companies that acquire
or partner with start-ups to conduct
thorough pre-acquisition compliance due
diligence. This should not only include
corruption risks, but new and evolving
risks, such as data privacy and cyber.
Use of wearables
Who decides if a specific use of data is
ethical?
Use of data obtained from a variety of
digital or mobile sources is a positive
trend, and one that will ultimately help
with the advancement of health care.
Using sensors and blockchain technology
to track patient data and real world
analytics may well become the norm — but
how will this data be used? Who owns
it? Companies need to consider their
protection and ethical use of digital data.
1
Industrial Revolution 4.0 is described as ‘a fusion of technologies that is blurring the lines between the physical, digital, and biological spheres.
Source: World Economic Forum
confirms a continued focus on this
sector — hence the need for companies to
enhance their compliance activity.
3. Digital disruption in the life sciences sector | 3
Use of new technology in
research and development
When there is limited human involvement,
how do you identify risk points on the
integrity of your clinical trials?
Robots and virtual reality tools are
increasingly used in the R&D phase of a
drug’s life cycle. While this reduces risk
of human error, other risks become more
prevalent, including data integrity and
cyber threats. This increases the need for
companies to adopt regular focused risk
assessments.
Interaction with HCPs
What if your only Key Opinion Leader in
the local market is a late adoptor of new
technology?
The future is likely to see robots
undertaking certain aspects of the
medical professional’s role. In the
meantime however, HCPs will continue
to prescribe or administer products,
retaining their status as key stakeholders
for life sciences companies.
What may increase the challenge in
interactions with the HCPs, however, will
be obtaining the ‘buy-in’ from them on the
latest products or advanced technologies.
This is compounded if the HCP shows a
preference for more traditional solutions,
leading to the possibility that companies
may resort to incentivizing HCPs through
improper or unethical means to use or
prescribe new offerings. As a result,
monitoring of interactions with — and
transfers of value to — HCPs are areas
that need constant focus — especially for
businesses with products at the cutting
edge of technology.
New ways to raise funds
You just received substantial funding — but
do you really know who your investor is?
As methods of R&D funding change,
so do the associated compliance risks.
While sourcing funds from a variety
of individuals can be fruitful, it is
essential to establish the true identity
of these individuals or entities. To
confirm that funds received are from
reputable as opposed to illegitimate
sources, companies should conduct
comprehensive business intelligence
checks on these investors.
Rise of the robots
How confident are you that your company
is protected from insider threats?
It is anticipated that advancement in
robotics and artificial intelligence will
put a portion of the world’s population
out of their jobs in the next 20 to 30
years. It is important to understand the
impact that departing employees may
have on companies. Such situations
may lead to disgruntled employees
calling their whistle-blower hotline
to report wrongdoing or attempt to
steal information from the company.
As a result, companies should be
conducting internal threat assessments
as well as reviewing the effectiveness of
their hotlines.
Continued reliance on third
parties
How do you determine that your latest
technology will not be appropriated by
unauthorized users?
A greater focus by governments, and in
particular the G20 major economies, to
promote greater transparency on the
ultimate beneficial ownership structure
of an entity is a development in the right
direction. This does not mean, however,
that risks associated with third parties
will disappear. Third parties, such as
distributors, continue to interact with
HCPs and government officials on behalf
of life sciences companies and represent
them in the market. Corruption risks
therefore remain — as does the need to
monitor them closely.
With the increased use of blockchain2
technology, which enhances supply chain
processes as well as the overall life cycle
of a product, companies and third parties
can track their products more efficiently.
With fewer “lost” items, the likelihood of
products being improperly acquired and
used is therefore reduced.
Another potential risk associated with
advanced technology relates to third —
party sanctions and export controls. With
the invention of digital and biologically
advanced products, the risk of these
products ending up in the wrong hands
for unintended purposes (e.g. terrorism)
increases. It is therefore crucial that
companies assess their export and
sanction controls.
Interactions with regulators
regarding non-traditional
products
Is there a difference in how you interact
with regulators for approval of traditional
versus disruptive products?
Non-traditional products include those
incorporating artificial intelligence or
3D printers. As the nature of products
undergoing regulatory approval changes,
so do the requirements and length of
time taken to obtain such approval.
There is still uncertainty around
how certain new products should be
regulated, such as products that can be
tailored for a patient’s genetic profile
(genomic medicine). While regulators are
formulating their approval process for
these innovative technologies, monitoring
of interactions with — and payments to —
government officials regarding obtaining
product approvals and registration in local
markets will continue to be a key focus.
Power of patients
Who decides the perceived outcome of a
product?
Patients are now more informed. They
believe they know what they need — and
they want to pay for a treatment based
on its outcome. An unclear definition
of what this outcome is, how it should
be measured and its correlation to
pricing are all likely to increase disputes
with regulators, purchasers or other
stakeholders. This potentially increases
the risk of corrupt activity. Compliance
programs should therefore include
controls to mitigate risks arising from
increased litigation.
Creation of demand for a product by
a company (or its competitors) paying
outsiders to write positive (or negative)
commentary about outcomes is also a key
risk. Conducting periodic media analytics
will help identify such occurrences.
2
Whilst the internet is a world-changing medium for information exchange, blockchain is “the first native digital medium for peer-to-peer value
exchange. Its protocol establishes the rules — in the form of globally distributed computations and heavy duty encryption — that ensure the integrity
of the data traded among billions of devices without going through a trusted third party.” — Source: http://www.ey.com/gl/en/industries/technology/
ey-blockchain-reaction-tech-plans-for-critical-mass